We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
(-0.26%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6
years
Top 10 Avg Time Held Equity + Options
2.7
years
Top 20 Avg Time Held Equity + Options
3.7
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$39.4M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$26.6M |
| 3 |
CVB Financial
CVBF
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$25.2M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$18.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$6.13M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.91M |
| 5 |
SS&C Technologies
SSNC
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.84% |
| 2 | Technology | 15.96% |
| 3 | Healthcare | 9.75% |
| 4 | Financials | 7.52% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
iShares Core International Aggregate Bond Fund
IAGG
$12.5B
| $400 | ﹤0.01% |
8
-367
| -98% | -$18.3K |
2023 Q2
7 quarters
|
|
3252
Sonic Automotive
SAH
$2.01B
| $399 | ﹤0.01% |
7
+4
| +133% | +$269 |
2024 Q4
1 quarter
|
|
3253
Vanda Pharmaceuticals
VNDA
$256M
| $399 | ﹤0.01% |
87
| – | – |
2024 Q1
4 quarters
|
|
3254
Ezcorp Inc
EZPW
$2.04B
| $397 | ﹤0.01% |
27
-6,016
| -100% | -$79.4K |
2024 Q2
3 quarters
|
|
3255
IMAX
IMAX
$2.83B
| $395 | ﹤0.01% |
+15
| New | +$374 |
2025 Q1
0 quarters
|
|
3256
DNOW Inc
DNOW
$2.72B
| $393 | ﹤0.01% |
+23
| New | +$348 |
2025 Q1
0 quarters
|
|
3257
Supernus Pharmaceuticals
SUPN
$2.3B
| $393 | ﹤0.01% |
12
| – | – |
2022 Q3
10 quarters
|
|
3258
Kalaris Therapeutics
KLRS
$52.1M
| $393 | ﹤0.01% |
49
-1
| -2% | -$10 |
2022 Q1
12 quarters
|
|
|
IRLA
3259
IRulya Therapeutics Inc. Common Stock
IRLA
$33.8M
| $392 | ﹤0.01% |
1
| – | – |
2020 Q1
20 quarters
|
|
3260
Taysha Gene Therapies
TSHA
$1.22B
| $389 | ﹤0.01% |
280
| – | – |
2024 Q2
3 quarters
|
|
3261
Braemar Hotels & Resorts
BHR
$95.5M
| $388 | ﹤0.01% |
156
| – | – |
2022 Q4
9 quarters
|
|
3262
Compass Pathways
CMPS
$1.61B
| $383 | ﹤0.01% |
134
| – | – |
2021 Q4
13 quarters
|
|
3263
Marcus & Millichap
MMI
$1.07B
| $379 | ﹤0.01% |
11
| – | – |
2023 Q4
5 quarters
|
|
3264
Orion Energy Systems
OESX
$95.1M
| $379 | ﹤0.01% |
53
| – | – |
2021 Q1
16 quarters
|
|
3265
SI-BONE Inc
SIBN
$892M
| $379 | ﹤0.01% |
27
+20
| +286% | +$323 |
2024 Q4
1 quarter
|
|
3266
Wolverine World Wide
WWW
$1.64B
| $376 | ﹤0.01% |
27
-58
| -68% | -$1.06K |
2021 Q1
16 quarters
|
|
3267
Federal Agricultural Mortgage
AGM
$2.24B
| $375 | ﹤0.01% |
2
| – | – |
2021 Q2
15 quarters
|
|
3268
Consensus Cloud Solutions
CCSI
$679M
| $369 | ﹤0.01% |
16
+14
| +700% | +$360 |
2021 Q4
13 quarters
|
|
3269
NETGEAR
NTGR
$606M
| $367 | ﹤0.01% |
15
| – | – |
2024 Q3
2 quarters
|
|
3270
Summit Therapeutics
SMMT
$12.3B
| $367 | ﹤0.01% |
+19
| New | +$381 |
2025 Q1
0 quarters
|
|
3271
Filana Therapeutics
FLNA
$36.8M
| $366 | ﹤0.01% |
244
| – | – |
2021 Q1
16 quarters
|
|
3272
IBEX
IBEX
$610M
| $365 | ﹤0.01% |
+15
| New | +$360 |
2025 Q1
0 quarters
|
|
3273
PagerDuty
PD
$1.36B
| $365 | ﹤0.01% |
20
-69
| -78% | -$1.27K |
2024 Q4
1 quarter
|
|
3274
Regis Corp
RGS
$73M
| $363 | ﹤0.01% |
20
| – | – |
2024 Q4
1 quarter
|
|
3275
Regenxbio
RGNX
$473M
| $358 | ﹤0.01% |
50
| – | – |
2020 Q1
20 quarters
|
|
Similar funds
Parallel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.
- Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
- Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
- Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
- Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
- Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
- Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.
Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.